
The choice of optimal drug therapy in patients with atrial fibrillation and comorbid pathology.
Author(s) -
M. I. Yalovenko,
О. О. Ханюков
Publication year - 2018
Publication title -
morfologìâ
Language(s) - English
Resource type - Journals
ISSN - 1997-9665
DOI - 10.26641/1997-9665.2018.4.104-115
Subject(s) - medicine , bisoprolol , atrial fibrillation , ramipril , cardiology , warfarin , atorvastatin , losartan , angina , metoprolol , stroke (engine) , rivaroxaban , coronary artery disease , anesthesia , heart failure , angiotensin ii , blood pressure , myocardial infarction , mechanical engineering , engineering